Alzheimer's drug decision reversed24th March 2011
The National Institute for Health and Clinical Excellence (NICE) has extended the use of three drugs to treat Alzheimer’s disease.
Aricept, exelon and reminyl are currently available through the NHS to sufferers of the condition who have moderate to severe symptoms but the drugs, which costs around £2.80 per patient per day, has now been approved for patients with milder problems. A fourth drug - ebixa - will be extended to people suffering more moderate symptoms after only previously being given to those in the late stages of the disease.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Alzheimer's drug decision reversed
Author: Mark Nicholls
Article Id: 17994
Date Added: 24th Mar 2011